COVID-19 and the Otolaryngologist: Preliminary Evidence-Based Review

The SARS-CoV-2 virus which causes coronavirus disease 2019 (COVID-19) has rapidly swept across the world since its identification in December 2019. Otolaryngologists are at unique risk due to the close contact with mucus membranes of the upper respiratory tract and have been among the most affected healthcare workers in Wuhan, China. We present information on COVID-19 management relevant to otolaryngologists on the frontlines of this pandemic and provide preliminary guidance based on practices implemented in China and other countries and practical strategies deployed at Stanford University.
Keywords: COVID-19, SARS-CoV-2, clinical practice guidelines, evidence-based medicine, infectious disease

The full article can be viewed here:
COVID-19: A Review for the Otolaryngologist